Latest CHI Advisors LLC Stock Portfolio
About CHI Advisors LLC and 13F Hedge Fund Stock Holdings
CHI Advisors LLC is a hedge fund based in NEW YORK, NY. On 12-Jan-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $707.5 Millions. In it's latest 13F Holdings report, CHI Advisors LLC reported an equity portfolio of $252.3 Millions as of 30 Sep, 2023.
The top stock holdings of CHI Advisors LLC are PLRX, RPTX, CGEM. The fund has invested 20.7% of it's portfolio in PLIANT THERAPEUTICS INC and 14.2% of portfolio in REPARE THERAPEUTICS INC.
The fund managers got completely rid off VECTIVBIO HLDG AG, HOOKIPA PHARMA INC (HOOK) and CORVUS PHARMACEUTICALS INC (CRVS) stocks. They significantly reduced their stock positions in DISC MEDICINE INC, PRECISION BIOSCIENCES INC (DTIL) and DIREXION SHS ETF TR (GUSH). CHI Advisors LLC opened new stock positions in MINERALYS THERAPEUTICS INC, BLUEPRINT MEDICINES CORP (BPMC) and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). The fund showed a lot of confidence in some stocks as they added substantially to ORCHARD THERAPEUTICS PLC (ORTX), FREELINE THERAPEUTICS HLDGS and ULTRAGENYX PHARMACEUTICAL IN (RARE).
The top stock holdings of CHI Advisors LLC are PLRX, RPTX, CGEM. The fund has invested 20.7% of it's portfolio in PLIANT THERAPEUTICS INC and 14.2% of portfolio in REPARE THERAPEUTICS INC.
The fund managers got completely rid off VECTIVBIO HLDG AG, HOOKIPA PHARMA INC (HOOK) and CORVUS PHARMACEUTICALS INC (CRVS) stocks. They significantly reduced their stock positions in DISC MEDICINE INC, PRECISION BIOSCIENCES INC (DTIL) and DIREXION SHS ETF TR (GUSH). CHI Advisors LLC opened new stock positions in MINERALYS THERAPEUTICS INC, BLUEPRINT MEDICINES CORP (BPMC) and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). The fund showed a lot of confidence in some stocks as they added substantially to ORCHARD THERAPEUTICS PLC (ORTX), FREELINE THERAPEUTICS HLDGS and ULTRAGENYX PHARMACEUTICAL IN (RARE).
New Buys
| Ticker | $ Bought |
|---|---|
| mineralys therapeutics inc | 5,405,280 |
| blueprint medicines corp | 4,664,840 |
| moonlake immunotherapeutics | 3,420,000 |
| sagimet biosciences inc | 3,069,810 |
New stocks bought by CHI Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| orchard therapeutics plc | 1,529 |
| freeline therapeutics hldgs | 299 |
| ultragenyx pharmaceutical in | 152 |
| syros pharmaceuticals inc | 69.31 |
| 2seventy bio inc | 17.61 |
| inozyme pharma inc | 6.28 |
| ikena oncology inc | 2.78 |
| keros therapeutics inc | 1.37 |
Additions to existing portfolio by CHI Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| disc medicine inc | -80.02 |
| precision biosciences inc | -62.17 |
| direxion shs etf tr | -30.77 |
| rallybio corp | -28.01 |
| acelyrin inc | -15.05 |
| black diamond therapeutics i | -4.00 |
| pliant therapeutics inc | -3.3 |
| repare therapeutics inc | -1.07 |
CHI Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vectivbio hldg ag | -46,945,100 |
| hookipa pharma inc | -694,091 |
| corvus pharmaceuticals inc | -458,000 |
CHI Advisors LLC got rid off the above stocks
CHI Advisors LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of CHI Advisors LLC
Last Reported on: 13 Nov, 2023| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| BDTX | black diamond therapeutics i | 0.82 | 720,000 | 2,066,400 | reduced | -4.00 | ||
| BPMC | blueprint medicines corp | 1.85 | 92,888 | 4,664,840 | new | |||
| CGEM | cullinan oncology inc | 12.25 | 3,414,190 | 30,898,400 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 2.21 | 2,829,710 | 5,574,530 | unchanged | 0.00 | ||
| CRVS | corvus pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DTIL | precision biosciences inc | 0.08 | 606,629 | 207,043 | reduced | -62.17 | ||
| GRPH | graphite bio inc | 0.23 | 230,938 | 572,726 | unchanged | 0.00 | ||
| GUSH | direxion shs etf tr | 1.84 | 225,000 | 4,635,000 | reduced | -30.77 | ||
| HOOK | hookipa pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IKNA | ikena oncology inc | 3.74 | 2,180,930 | 9,443,440 | added | 2.78 | ||
| INZY | inozyme pharma inc | 2.11 | 1,270,030 | 5,334,110 | added | 6.28 | ||
| KROS | keros therapeutics inc | 5.15 | 407,633 | 12,995,300 | added | 1.37 | ||
| LRMR | larimar therapeutics inc | 5.35 | 3,414,470 | 13,487,100 | unchanged | 0.00 | ||
| MLTX | moonlake immunotherapeutics | 1.35 | 60,000 | 3,420,000 | new | |||
| OMGA | omega therapeutics inc | 0.90 | 1,055,880 | 2,270,150 | unchanged | 0.00 | ||
| ORTX | orchard therapeutics plc | 5.56 | 12,315,700 | 14,034,800 | added | 1,529 | ||
| OVID | ovid therapeutics inc | 1.32 | 864,822 | 3,320,920 | unchanged | 0.00 | ||
| PLRX | pliant therapeutics inc | 20.72 | 3,014,200 | 52,266,200 | reduced | -3.3 | ||
| RARE | ultragenyx pharmaceutical in | 3.04 | 215,000 | 7,664,750 | added | 152 | ||
| RLYB | rallybio corp | 0.52 | 390,734 | 1,316,770 | reduced | -28.01 | ||